Diagnosis and treatment of thyroiditis

doi:10.3969/j.issn.1004-583X.2016.03.011

Abstract

Abstract: Thyroiditis is a heterogeneous disease involving the thyroid.Its type and classification in many ways,but subacute thyroiditis　and　chronic lymphocytic thyroiditis are most frequently seen clinically. Subacute thyroiditis is caused by virus infection and pathogenesis of chronic lymphocytic thyroiditis is autoimmune.The review discusses about clinical manifestations,diagnosis,treatment,and some progresses of thyroiditis in order to provide references for physicians in diagnosis and therapy of thyroiditis.

Key words: trialfibrillation, anticoagulants, thyroiditis, subacute, thyroiditis, autoimmune, diagnosis, treatment progress

CLC Number:

R581.4

Ning Cuili,Wu Mengshui,Liu Kuanzhi. Diagnosis and treatment of thyroiditis[J]. Clinical Focus, 2016, 31(3): 277-281.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.03.011

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I3/277

References

[1] 王景彩,沈墙.亚急性甲状腺炎超声特征与中医证型相关性的探讨[J].天津中医药,20 12,11(2):134-135.
[2] 王志宏,赵芹.亚急性甲状腺炎24例的彩色多普勒诊断及鉴别[J].实用医学影像杂志,2010,29(3):234-235.
[3] Kubota S, Nishihara E, Kudo T, et al. Initial treatment with 15 mg of prednisolone daily is sufficient for most patients with subacute thyroiditis in Japan[J]. Thyroid, 2013, 23(3): 269-272.
[4] Su Zhen li,Ma Li,Gao lin.Clinical observation of local injection of dexamethasone in patients with subacute thyroiditis[J]. China practical medicine,2012,11(23) :552-553.
[5] Michels AW,Eisenbarth GS.Immunologic endocrine disorders[J].J Allergy Clin Immunol,2010,125(2):269-272.
[6] 初平,王棽,齐展,等.甲状腺过氧化物酶表达在桥本氏甲状腺炎诊断价值的 Meta分析[J].标记免疫分析与临床,2014,21(1):6-11.
[7] 战大伟,王敏,姜俊友.甲状腺球蛋白抗体、甲状腺过氧化物酶抗体在诊断甲状腺疾病中的临床意义[J].中国地方病防治杂志,2014,29(2):126.
[8] 贾建伟,温凤萍.115例桥本甲状腺炎的超声诊断分析[J].影像与介入,2010,17(7):75-76.
[9] 李传红,宋修芹,张良岩,等.桥本甲状腺炎超声声像图分析[J].中华医学超声杂志,2012,9(1):71-74.
[10] 郑蓉,张丹.桥本甲状腺炎的诊断进展[J].中华临床医师杂志,2013,7(4):1687-1689.
[11] 雒亚梅,李海伟.地塞米松联合甲状腺素钠治疗桥本甲状腺炎疗效观察[J]. 基层医学论坛,2015, 19(2):169-171.
[12] 张金海,宋金明,袁正强,等.甲状腺内注射地塞米松治疗桥本甲状腺炎的疗效[J].中国地方病防治杂志,2014,29(1): 70-71.
[13] 陈鹤华.甲状腺内注射地塞米松和环磷酰胺治疗桥本甲状腺炎的临床疗效分析[J].中外医学研究,2014,12(28):133-134.
[14] 朱文,宋晓敏,王博,等.硒酵母辅助优甲乐治疗桥本甲状腺炎甲状腺功能减退临床疗效观察[J].中国医药导刊,2014,16(4):701-702.
[15] 赵晓南.桥本甲状腺炎性甲亢行硒联合抑亢丸、甲巯咪唑治疗的疗效分析[J].中国实用医药,2015,10(5):172-173.
[16] 刘杉,熊丰,刘恩梅,等.1,25(OH)₂D₃干预实验性自身免疫性甲状腺炎TH1/TH2细胞失衡的研究[J].南方医科大学学报,2015,30(7):1573-1576.
[17] 李娜,蒋筠,严率,等.血清维生素 D 水平与桥本甲状腺炎的相关性分析[J].世界临床药物,2015,36(9):591-595.
[18] 韩英,陈玉娟,李咏梅,等.骨化三醇治疗对桥本甲状腺炎合并甲状腺功能减退的影响[J].中国临床研究,2015,28(1):17-23.
[19] 朱俐鲆,刘素荣,王德双,等.桥本1号方治疗桥本甲状腺炎临床观察[J].实用中医药杂,2015,31(3):187-188.
[20] 李玲,陈晓雯.耳穴埋豆法治疗桥本甲状腺肿30例[J].江西中医学院学报,2013,25(4):37-39.
[21] 张维佳,张振贤,夏翔,等.固本消散方治疗桥本氏甲减 62例临床[J].实用临床医药杂志,2015,19(11):156-158.
[22] 李昀昊,杨宏杰,何燕铭,等.中药复方对桥本甲状腺炎患者细胞因子和抗体的影响[J].上海交通大学学报,2015,35(8)1174-1178.
[23] Wirtschafter A,Schmidt R,Rosen D,et al.Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto thyroiditis[J].Laryngoscope,1997,107(10),95-100.
[24] 艾志龙.桥本甲状腺炎的外科诊治[J].外科理论与实践,2014,19(3):205-207.
[25] 许琪,蔡春花,陈慎仁.小剂量甲氨蝶呤治疗高甲状腺过氧化物酶抗体血症观察[J].药物流行病学杂志,2013,22(8) :410-412.
[26] 汪茂荣,姚平,陈碧玲,等.幽门螺杆菌感染与自身免疫性甲状腺炎的相关性研究[J].中华医院感染学杂志,2015,25(5):1984-1986.
[27] 张玮.百令胶囊对桥本氏甲状腺炎患者过氧化物酶抗体的影响[J].实用临床医学,2015,16(4):23-24.
[28] 黄芮.夏枯草功效学和毒理学研究进展[J].中国公共卫生,2013,29(7):1083-1085.
[29] 魏静,田建卿,陈江辉,等.左甲状腺素钠与夏枯草胶囊对桥本甲状腺炎的临床疗效[J].检验医学与临床,2014,11(24):3430-3432.